News | March 17, 2022
Biological E gears up for new phase of vaccination drive
To date, 30 crore vaccines have been produced as part of the commitment made to the Government of India
To date, 30 crore vaccines have been produced as part of the commitment made to the Government of India
Novartis data again demonstrate age-appropriate development when Zolgensma is used presymptomatically, and post-hoc data reveal SMA Type 1 patients could speak, swallow and maintain airway protection
The money will be donated to the United Nations Children’s Fund (UNICEF)
Colchicine tablets are used for the treatment and prevention of gout. It reduces inflammation which causes pain, swelling and other symptoms of gout
As the world celebrates World Glaucoma Week (March 7-13th), Nikkhil K Masurkar, Executive Director, Entod Pharmaceuticals, an authority on eye diseases spoke to Thomas C Thottathil, Editor, indianpharmapost.com, on the seriousness of Glaucoma
Paxlovid is the first oral therapy specifically designed to combat Covid-19 to be evaluated in a pediatric clinical study
Nulibry is approved by the U.S. Food and Drug Administration (USFDA) to reduce the risk of mortality in patients with molybdenum cofactor deficiency (MoCD) Type A, an ultra-rare, life-threatening paediatric genetic disorder
The DCGI has already approved Covovax for restricted use in emergency situations in adults on December 28th 2021
Raising awareness about glaucoma is crucial in India where it is the leading cause of irreversible blindness with at least 12 million people affected and almost 1.2 million people blind from the disease
Women's health is in fact a direct reflection of the nation's overall health
Subscribe To Our Newsletter & Stay Updated
